wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33770680-A8C832D4-6B65-43AA-A63F-D089FFB306EF
Q33770680-A8C832D4-6B65-43AA-A63F-D089FFB306EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33770680-A8C832D4-6B65-43AA-A63F-D089FFB306EF
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.
P2860
Q33770680-A8C832D4-6B65-43AA-A63F-D089FFB306EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33770680-A8C832D4-6B65-43AA-A63F-D089FFB306EF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
67a295ce8fdf9621a6fc639b607fb010871e124c
P2860
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.